Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
A Retrospective Cohort Study of the Clinicopathological and Treatment Characteristics Associated with the Development of Prostate Cancer Metastases to the Liver
EF 2022-23
Résumé
More than 4,000 Canadian men die annually from metastatic prostate cancer. Although numerous life-prolonging therapies have become available during the last fifteen years, metastatic prostate cancer remains incurable.
Prostate cancer metastases to the liver are relatively rare (15% of patients). However, compared to metastases to bones (90%) or lymph nodes (50%), liver metastases are associated with significantly worse survival. Moreover, there is a lack of data identifying which prostate cancer patients are at increased risk of liver metastasis.
Thus, in the proposed study, we plan to analyze 1,000 patients with metastatic prostate cancer to identify baseline patient and disease characteristics (i.e., from the time of initial diagnosis) as well as the type and number of prior therapies, predicting the development of liver metastasis. Such predictive factors could help identify men suitable for frequent liver scans. In turn, this would allow for the design of clinical studies aimed at reducing the risk of liver metastasis or the ability to treat liver metastases before they become too numerous for successful therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486231
Name
Shiner Audrey
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Retrospective Cohort Study of the Clinicopathological and Treatment Characteristics Associated with the Development of Prostate Cancer Metastases to the Liver
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Generational Real-World Evidence; Good Clinical Practice; Liver Metastasis; Prostate Cancer; Retrospective Chart Review
Abstract
More than 4,000 Canadian men die annually from metastatic prostate cancer. Although numerous life-prolonging therapies have become available during the last fifteen years, metastatic prostate cancer remains incurable.
Prostate cancer metastases to the liver are relatively rare (15% of patients). However, compared to metastases to bones (90%) or lymph nodes (50%), liver metastases are associated with significantly worse survival. Moreover, there is a lack of data identifying which prostate cancer patients are at increased risk of liver metastasis.
Thus, in the proposed study, we plan to analyze 1,000 patients with metastatic prostate cancer to identify baseline patient and disease characteristics (i.e., from the time of initial diagnosis) as well as the type and number of prior therapies, predicting the development of liver metastasis. Such predictive factors could help identify men suitable for frequent liver scans. In turn, this would allow for the design of clinical studies aimed at reducing the risk of liver metastasis or the ability to treat liver metastases before they become too numerous for successful therapy.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shiner, Audrey
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~